Skip to main content
THRM
NASDAQ Manufacturing

Record $416M Q2 Revenue Powers Gentherm's Guidance Raise and $400M Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Automotive Stocks · Consumer
Sentiment info
Positive
Importance info
8
Price
$45.2
Mkt Cap
$1.399B
52W Low
$27
52W High
$45.96
52W Position info
67% above low
Off High info
1.7% below high
Rel. Volume info
4.8× avg
Market data snapshot near publication time

THRM sits 67% above its 52-week low of $27 on elevated volume (4.8× avg).

Summary

Record Q2 revenue of $416.2M led Gentherm to raise full-year guidance and authorize a new $400M stock buyback, as restructuring and expansion pave the way for the Modine merger.


Key Events · Earnings and Guidance · THRM

  • Record Q2 Revenue

    Product revenues climbed 11% to $416.2 million, up from $375.1 million in Q2 2025, fueled by robust automotive volumes.

  • Raised Full-Year Guidance

    Following the strong Q2 performance, management raised its 2026 outlook, though the 10-Q did not disclose specific guidance figures.

  • $400M Stock Buyback Authorized

    Signaling confidence in the stock, the board terminated the prior $150M repurchase program and authorized a new $400M buyback, expiring July 2029.

  • Restructuring Charges Continue

    Restructuring expenses reached $6.0 million in Q2 and $12.7 million year-to-date, primarily covering employee separation costs under the 2026 Plan.


Analysis · THRM · Manufacturing

A record quarterly revenue of $416.2 million—up 11% year-over-year—drove Gentherm to lift its full-year outlook and authorize a new $400 million stock buyback, replacing a prior $150 million plan. The move underscores management's confidence in cash generation and current valuation. The quarter also absorbed $6.0 million in restructuring charges as the company streamlines operations ahead of the pending Modine merger. A new $550 million credit facility strengthened the balance sheet, while the medical segment expanded with the $34 million acquisition of IME, which closed on July 1. Together, these actions position Gentherm for the transformative Modine transaction, expected to close by early Q4 2026.

At the time of this filing, THRM was trading at $45.20 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $27.00 to $45.96. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

THRM - Latest Insights

THRM
Jul 23, 2026, 10:43 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
THRM
Jul 23, 2026, 6:11 AM EDT
Filing Type: 425
Importance Score:
8
THRM
Jul 23, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
THRM
Jul 23, 2026, 6:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
THRM
Jul 22, 2026, 4:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
7